101 related articles for article (PubMed ID: 9173082)
1. Normal and transforming Ras are differently regulated for posttranslational modifications.
Yamada-Okabe T; Doi R; Yamada-Okabe H
J Cell Biochem; 1996 May; 61(2):172-81. PubMed ID: 9173082
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells.
Chen TM; Defendi V
Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402
[TBL] [Abstract][Full Text] [Related]
4. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
7. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
Cox AD; Brtva TR; Lowe DG; Der CJ
Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
[TBL] [Abstract][Full Text] [Related]
8. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
9. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
11. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
[TBL] [Abstract][Full Text] [Related]
12. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence.
Carystinos GD; Kandouz M; Alaoui-Jamali MA; Batist G
Mol Pharmacol; 2003 Apr; 63(4):821-31. PubMed ID: 12644583
[TBL] [Abstract][Full Text] [Related]
13. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
14. [Enhancement of cellular transforming activities of truncated EJ c-H-ras-1 with viral enhancers or with c-myc].
Koyama T
Kokubyo Gakkai Zasshi; 1990 Dec; 57(4):562-79. PubMed ID: 2081937
[TBL] [Abstract][Full Text] [Related]
15. Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci.
Chen TH; Brody JR; Romantsev FE; Yu JG; Kayler AE; Voneiff E; Kuhajda FP; Pasternack GR
Mol Biol Cell; 1996 Dec; 7(12):2045-56. PubMed ID: 8970164
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
Saez R; Chan AM; Miki T; Aaronson SA
Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
[TBL] [Abstract][Full Text] [Related]
17. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
18. A role for myn in Ha-ras transformation of mouse 10T1/2 fibroblasts.
Taylor WR; Wright JA
Mol Carcinog; 1994 May; 10(1):8-14. PubMed ID: 8185831
[TBL] [Abstract][Full Text] [Related]
19. Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.
Lu X; Park SH; Thompson TC; Lane DP
Cell; 1992 Jul; 70(1):153-61. PubMed ID: 1623518
[TBL] [Abstract][Full Text] [Related]
20. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.
Niimi S; Nakagawa K; Yokota J; Tsunokawa Y; Nishio K; Terashima Y; Shibuya M; Terada M; Saijo N
Br J Cancer; 1991 Feb; 63(2):237-41. PubMed ID: 1997100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
